Mutation-independent anaplastic lymphoma kinase overexpression in poor prognosis neuroblastoma patients. - Wikidata - wikimedia - TriplyDB

Mutation-independent anaplastic lymphoma kinase overexpression in poor prognosis neuroblastoma patients.

Mutation-independent anaplastic lymphoma kinase overexpression in poor prognosis neuroblastoma patients.

http://www.wikidata.org/entity/Q39805159

about

Emerging importance of ALK in neuroblastoma Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study.Novel ALK inhibitor AZD3463 inhibits neuroblastoma growth by overcoming crizotinib resistance and inducing apoptosis.Protein glycosylation in cancers and its potential therapeutic applications in neuroblastoma The zebrafish as a model for studying neuroblastoma Molecular pathogenesis of peripheral neuroblastic tumors Overview and recent advances in the treatment of neuroblastoma.Glycobiology of neuroblastoma: impact on tumor behavior, prognosis, and therapeutic strategies.PHOX2B-mediated regulation of ALK expression: in vitro identification of a functional relationship between two genes involved in neuroblastoma.In vitro and in vivo inhibition of neuroblastoma tumor cell growth by AKT inhibitor perifosine New aspects of neuroblastoma treatment: ASPHO 2011 symposium review Wild-type ALK and activating ALK-R1275Q and ALK-F1174L mutations upregulate Myc and initiate tumor formation in murine neural crest progenitor cells Inhibition of N-linked glycosylation impairs ALK phosphorylation and disrupts pro-survival signaling in neuroblastoma cell lines.Platform comparison for evaluation of ALK protein immunohistochemical expression, genomic copy number and hotspot mutation status in neuroblastomas Neuroblastoma-targeted nanoparticles entrapping siRNA specifically knockdown ALK.Cooperative Cross-Talk between Neuroblastoma Subtypes Confers Resistance to Anaplastic Lymphoma Kinase Inhibition.Selective therapeutic targeting of the anaplastic lymphoma kinase with liposomal siRNA induces apoptosis and inhibits angiogenesis in neuroblastoma The role of intracellular calcium for the development and treatment of neuroblastoma.Insights into the Molecular Pathogenesis of Activated B-Cell-like Diffuse Large B-Cell Lymphoma and Its Therapeutic Implications.In search of targeted therapies for childhood cancer.Promising therapeutic targets in neuroblastoma Molecular profiling of childhood cancer: Biomarkers and novel therapies Alternative transcription initiation leads to expression of a novel ALK isoform in cancer.Targeting ALK in neuroblastoma--preclinical and clinical advancements.Cell survival signaling in neuroblastoma.ERBB3 is a marker of a ganglioneuroblastoma/ganglioneuroma-like expression profile in neuroblastic tumours.ALK is a MYCN target gene and regulates cell migration and invasion in neuroblastoma.Identification of different ALK mutations in a pair of neuroblastoma cell lines established at diagnosis and relapse.The connections between neural crest development and neuroblastoma.Cytokines in neuroblastoma: from pathogenesis to treatment.New targets and targeted drugs for the treatment of cancer: an outlook to pediatric oncology.Preclinical drug development for childhood cancer.Targeting ALK: a promising strategy for the treatment of non-small cell lung cancer, non-Hodgkin's lymphoma, and neuroblastoma.The role of genetic and epigenetic alterations in neuroblastoma disease pathogenesis.New insights into the genetics of neuroblastoma.Modular nanotransporters for targeted intracellular delivery of drugs: folate receptors as potential targets.New immunotherapeutic strategies for the treatment of neuroblastoma.Anaplastic Lymphoma Kinase as a Cancer Target in Pediatric Malignancies.Tumor Antigen and Receptor Densities Regulate Efficacy of a Chimeric Antigen Receptor Targeting Anaplastic Lymphoma Kinase.Combating autophagy is a strategy to increase cytotoxic effects of novel ALK inhibitor entrectinib in neuroblastoma cells.

P2860

Q26858819-A5B2CF7A-D46E-4F0D-936E-F3E695C7DF1F Q27852211-C95C9EA4-8BE5-4F1C-9AAC-BA06F7BECEED Q27853323-2452C7FE-00EE-420C-9354-7EE696C04066 Q28069952-9EA8CA8A-D806-4DE4-8359-57FFDE6C8D08 Q28070309-50ADE4AD-5293-4CC3-BFE0-522AC851A117 Q28271405-D5F1D7F9-6A1E-4A44-A966-858485058EBB Q30238693-E3E50066-E339-42E7-B1E6-667263AE1A20 Q33659849-986296DE-D0E5-4918-8911-B9D39A0668E1 Q33721880-605C422A-B09D-4C32-8E35-930468A91662 Q33888833-FD2F82A5-4DA2-48C7-AE42-AF7897FBC39B Q33922797-EDA81CB4-664D-4F09-A121-3C6C5D41C1F5 Q34101007-C296012F-F9AF-4D72-851E-B8F66623BCA4 Q34109019-31F0AE3F-9D6A-4485-BB23-BCDE7478669F Q34134105-A6C7B31A-829D-4AE2-8EE0-9C26F9A18C54 Q35086721-359A926D-A0D8-4FB7-A8C1-B76FE00CDBE1 Q35180335-07053BC7-CDB6-4B42-9F81-970CE4DE7807 Q35623435-726553EF-D757-4FBE-B905-D15BCD58710E Q35818437-DFA73F0A-8E40-4A68-AD8F-6EAFD28635DA Q35818443-64812E28-CFCF-421C-8BA2-6F2928FA7FC0 Q35971733-96F1764A-6EEE-4739-B17D-BBF17E9A7D5C Q36055313-0FCEA941-A712-4AC1-A1A1-A15207A9B106 Q36250783-6C78AB3E-F7CF-465F-A93C-6DFF9A14BE94 Q36726792-C090D7C8-4637-4733-BE89-1E99EC23604D Q36933081-426F1963-BC39-4189-88D1-5E8ABB75F875 Q37010166-9BAA5F0E-9D70-4AE9-847B-B10D65681A89 Q37154010-7E99C0E9-6979-4D4E-861B-81399BCBD2F7 Q37405597-C1BB9604-A59F-4789-9FF0-45C741A76826 Q37699419-E30B5FBD-FDEF-46AC-9E4C-589A31158906 Q37836006-21E23A08-2FB4-4D9A-B556-9D56099DA034 Q37900650-20CFA5F8-F7C0-4804-BAC1-18F86F694E54 Q37936432-264A306E-6D70-4813-A294-CA2338128169 Q38014543-9B1863F5-8DA4-4D06-A72C-E1281EB41210 Q38042570-C711F277-82E6-4985-B2F2-4654634409E5 Q38070334-D9843544-0D82-49D0-B916-35DBA2B32E2D Q38074875-4B25E646-B40C-4FAF-941A-BEA109BB4935 Q38259956-96E3084E-DEFA-4CC5-B42E-C7EAF44EC7D2 Q38389316-6F1B2927-7A30-4ABF-9E42-EAB94FB1034F Q38616826-EA2A7550-8A12-49EB-B83A-DBCDDBD7D4EB Q38694036-3C8C105F-EB93-44E1-894F-AB0DA28A3503 Q38806238-E62081D7-13B3-4EBA-ABFF-04A6F4681344

P2860

Mutation-independent anaplastic lymphoma kinase overexpression in poor prognosis neuroblastoma patients.

http://www.wikidata.org/entity/Q39805159

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh

2009年學術文章

@zh-hant

name

Mutation-independent anaplasti ...... gnosis neuroblastoma patients.

@en

Mutation-independent anaplasti ...... gnosis neuroblastoma patients.

@nl

type

label

Mutation-independent anaplasti ...... gnosis neuroblastoma patients.

@en

Mutation-independent anaplasti ...... gnosis neuroblastoma patients.

@nl

prefLabel

Mutation-independent anaplasti ...... gnosis neuroblastoma patients.

@en

Mutation-independent anaplasti ...... gnosis neuroblastoma patients.

@nl

P1433

Q39805159-406137B0-B566-4ACD-9AD5-893F51CBDEE8

P1476

Q39805159-DD929580-B251-43F1-B191-FCC20D5F884C

P2093

Q39805159-1F096491-C91B-4A62-B85B-0BDAC3A329D9

Q39805159-278BA6AB-2E99-4CBD-ABA1-32EE1A835B9C

Q39805159-A04F5B0E-2611-4CF4-93AF-6570BF4D7A6C

Q39805159-B2A91406-7BC2-4B29-A7B7-D18D47486078

Q39805159-D69E8629-2A23-44B0-BCB7-B054E842765D

Q39805159-D6FE8E29-F315-43DE-838A-D7B9402F153B

Q39805159-E392AC1D-05A1-403E-94DF-93A89DEB2959

Q39805159-FAEE8486-7513-421D-9B84-31B733708C5E

P304

Q39805159-B29D0FCB-1E81-4100-A683-8D78A9FDCE35

P31

Q39805159-FB21D7D3-EE7B-4B1F-9B1A-CFF6FF10FC2B

P356

Q39805159-B9920995-642B-4D22-B82A-B408D7FD9168

P407

Q39805159-10911902-EF7E-4414-874A-D8F7D07A87B9

P433

Q39805159-D29694D2-DCD2-4E4D-AC1C-AA1D1C2FB0C5

P478

Q39805159-3CD265B9-6C26-4541-9A17-37BE84D67819

P50

Q39805159-225FBE2A-46AE-4B85-8F68-055C2E6590A1

Q39805159-27122BB0-7167-4736-B1CA-856B42FEC4CC

Q39805159-419F0452-6731-49CC-848F-B56836EB52B0

Q39805159-6E889D4E-5C57-4FBF-A78F-37E43A691DF8

Q39805159-6F7EA754-66BB-427B-B1AA-6116A340885A

Q39805159-836D8CE2-6EEA-47EC-820A-B44DD356142F

Q39805159-8524F70B-EEC7-4E72-AD6A-0B8A9C620BD2

Q39805159-B7D3E722-653F-4920-892F-F1344A81B532

Q39805159-B8DA7475-6B39-4114-98F0-E6A15F18DFD5

Q39805159-C6C2EB30-236A-4C39-AB56-133CFDCCBD78

P577

Q39805159-2BF37AE8-C8B7-4ED3-9072-31F04C98C84B

P5875

Q39805159-B99C497F-21C9-4769-9331-87761C41A8EA

P698

Q39805159-D803CA38-3BE7-47B2-81CD-3AA4BAE55784

P921

Q39805159-79527AD5-1DEA-45FE-9B8A-112094AC6A7D

Q39805159-E2BEDA3C-9A3B-4113-83DE-9E5E1D0C656E

P356

0008-5472.CAN-08-4419

P1433

Cancer Research

P1476

Mutation-independent anaplasti ...... gnosis neuroblastoma patients.

@en

P2093

Addolorata Maria Luce Coluccia

http://www.w3.org/2001/XMLSchema#string

Andrea Gregorio

http://www.w3.org/2001/XMLSchema#string

Claudio Gambini

http://www.w3.org/2001/XMLSchema#string

Federica Del Grosso

http://www.w3.org/2001/XMLSchema#string

Franca Fossati-Bellani

http://www.w3.org/2001/XMLSchema#string

Gian Paolo Tonini

http://www.w3.org/2001/XMLSchema#string

Mangeng Cheng

http://www.w3.org/2001/XMLSchema#string

Vito Pistoia

http://www.w3.org/2001/XMLSchema#string

P304

7338-7346

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/0008-5472.CAN-08-4419

http://www.w3.org/2001/XMLSchema#string

P407

P433

18

http://www.w3.org/2001/XMLSchema#string

P478

69

http://www.w3.org/2001/XMLSchema#string

P50

Carlo Gambacorti-Passerini

Andrea Anichini

Massimo Di Nicola

Alberto Garaventa

P577

2009-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26783098

http://www.w3.org/2001/XMLSchema#string

P698

19723661

http://www.w3.org/2001/XMLSchema#string

P921